维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="E Laack"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，1：	1
2	Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer显示文摘	Laack E Kohler A Kugler C	2002	Ann Oncol2002，13，10：	1
3	Hand-foot syndrome associated with short infusions of combination chemotherapy with gecitabine and vinorelbine显示文摘	Laack E Mende T Knuffmann C	2001	Ann Oncol2001，12，12：	1
4	Pretrcatment vascular endothelial growth factor (vegf) and matrix metallopruteinase-9 (mmp-9) serum levels in patients with metastatic non-small cell lung cancer (nsclc)显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，：	1
5	Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small lung eaneer显示文摘	Laack E Kohler A Kugler C	2002	Ann Oncol2002，13，10：	1
6	Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘	LAACK E SCHEFFLER A BURKHOLDER I	2005	Lung Cancer2005，50，1：	1
7	Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non small-cell lung cancer显示文摘	Laack E Nohler A Kugler C	2002	Ann Oncol2002，13，10：	1
8	Pretreatmrent serum levers of matrix- metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer显示文摘	Laack E Kohler A Kugler C	2002	Ann Oncol2002，13，：	1
9	Expression of CEACAM-1 in adenocarcinoma of the lung: a factor of independent prognostic significance 显示文摘	Laack E Nikbakht H Peters A	2002	Clin Oncol2002，20，21：	1
10	Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small- lung cancer显示文摘	Laack E Kohler A Kugler C	2002	Ann Oncol2002，13，10：	1
11	Gemcitabine,vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:a phase Ⅱ trial显示文摘	Laack E Mende T Durk H	2002	Eur J Cancer2002，38，5：	1
12	Pretreatmentvascu- lar endothelial growth factor (VEGF) and matrix metallopro- teinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，1：	1
13	Pretreatment vascular endothelial growth faetor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC) 显示文摘	LAACK E SCHEFFLER A BURKHOLDER I	2005	Lung Cancer2005，50，1：	1
14	Maintenance pemetrexed (Pem)plus best supportive care (BSC)versus placebo (Plac)plus BSC:A randomized phase III study in advanced non-small cell lung cancer (NSCLC)显示文摘	Belani CP Brodowicz T Ciuleanu T Kim JH Krzakowski M Laack E Wu YL Peterson P Krejcy K.Zielinski C		0，，18：	1
15	Pretreatment vascular endothelial growth factor(VEGF)and matrix metallo proteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，1：	1
16	IgM myelonm: a report of tour cases显示文摘	Dierlamm T Laack E Dierlamm J	2002	Ann Hematol2002，81，3：	1
17	Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer 显示文摘	Laack E Kohler A Kugler C	2002	Ann Oncol2002，13，10：	1
18	Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9 ( MMP-9 ) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，1：	1
19	Pretreatment vascularendothelial growth factor ( VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small celllung cancer( NSCLC)显示文摘	Laack E Scheffler A Burkholder I	2005	Lung Cancer2005，50，1：	1
20	Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9)serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘	Laack E Scheffler A Burkholder I		0，，01：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示